-
公开(公告)号:US20230201031A1
公开(公告)日:2023-06-29
申请号:US18145437
申请日:2022-12-22
申请人: Alcon Inc.
CPC分类号: A61F9/007 , A61F2/142 , A61F9/0017 , A61L17/10 , A61L31/148
摘要: A dissolvable medical device for placing on the outer exposed surface of the eye to heal the corneal wound comprising of: a polymeric film has sufficient dimensions to substantially cover a cornea when applied to an eye, wherein the polymeric film comprising one or more mucoadhesive polymers, wherein the polymeric film dissolves between 15 minutes to 120 minutes to release the mucoadhesive polymers, wherein the dissolved polymeric film is not impeding visualization of ocular tissue while maintaining a protective film on outer surface of the eye.
-
公开(公告)号:US20240166691A1
公开(公告)日:2024-05-23
申请号:US18503390
申请日:2023-11-07
申请人: Alcon Inc.
IPC分类号: C07K7/64
CPC分类号: C07K7/645
摘要: The present disclosure is directed to prodrugs, compositions including prodrugs, and methods for administering prodrugs and compositions thereof to a patient, including prodrugs represented by Formula (I):
wherein: D is a drug moiety; Q is an oxygen atom, a sulfur atom, or a nitrogen atom; X is a chemical bond or
each of G, G′, and G″ is independently an oxygen atom or a sulfur atom; L is a polyether; T is a hydrogen atom, a hydroxyl group, a thiol group, a boronic acid group, or an amine group; R1 is selected from the group consisting of a substituted aryl group, unsubstituted aryl group, and a substituted carbonyl group; and each of R2, R3, R1′, R2′, R3′, and R4′ is independently a hydrogen atom, a substituted C1-C20 alkyl group, or an unsubstituted C1 -C20 alkyl group. In at least one embodiment, a composition comprises a compound and a carrier material.-
公开(公告)号:US20230201112A1
公开(公告)日:2023-06-29
申请号:US18145256
申请日:2022-12-22
申请人: Alcon Inc.
CPC分类号: A61K9/0051 , A61K9/70 , A61K47/36 , A61K47/32 , A61K47/10
摘要: A dissolvable medical device for protecting a corneal surface and providing lubrication and hydration to the corneal surface during ophthalmic surgery comprising: a polymeric film has sufficient dimensions to substantially cover a cornea when applied to an eye, wherein the polymeric film comprising one or more mucoadhesive polymers. The polymeric film dissolves between 15 minutes to 120 minutes to release the mucoadhesive polymers after applying the polymeric film to the eye and the polymeric film provides more effective corneal surface protection relative to a saline treatment based on Mean Green Fluorescence Index test (demonstrates corneal damage) during a simulated surgery. In addition, a kit for use in ophthalmic surgical procedures comprises 1) the at least one dissolvable medical device and 2) at least one viscosurgical viscoelastic or at least one ophthalmoscopic surgical contact lens.
-
公开(公告)号:US12102559B2
公开(公告)日:2024-10-01
申请号:US16864894
申请日:2020-05-01
申请人: ALCON INC.
CPC分类号: A61F9/0017 , A61K9/0051 , A61K47/10 , A61K47/14 , A61K47/22 , A61K47/36 , A61K2121/00
摘要: Polymeric eye inserts are provided that may be dissolvable when placed in the cul-de-sac of the eye. These inserts may contain one or more polymers as well as a softener/plasticizer so that, when inserted into the eye, they may absorb tears, and dissolve and slowly release lubricant into the tear film to lubricate and protect the ocular surface for an extended duration of time. Increased retention time on the ocular surface for longer lasting relief may reduce dosing frequency and patient burden typically associated with topical drop usage. These polymeric eye inserts also may include one or more pharmaceutically active agents.
-
公开(公告)号:US20240307355A1
公开(公告)日:2024-09-19
申请号:US18604926
申请日:2024-03-14
申请人: ALCON INC.
发明人: Rekha Rangarajan , Howard Allen Ketelson , Randall Renato Kolega , Mark Joseph Bridle , Alexei Grigoryevich Merzlikine
IPC分类号: A61K31/4168 , A61K9/00 , A61K9/08 , A61K47/02 , A61K47/12 , A61K47/18 , A61K47/38 , A61P27/02
CPC分类号: A61K31/4168 , A61K9/0048 , A61K9/08 , A61K47/02 , A61K47/12 , A61K47/186 , A61K47/38 , A61P27/02
摘要: The present disclosure is directed to pharmaceutical compositions comprising apraclonidine and a polymer, wherein the apraclonidine is present at greater than 0.05% (w/v) to no more than 0.2% (w/v) based on the total volume of the pharmaceutical composition, methods of preparing the same and methods for reducing ocular redness by administering the same.
-
6.
公开(公告)号:US20220323346A1
公开(公告)日:2022-10-13
申请号:US17808342
申请日:2022-06-23
申请人: Alcon Inc.
IPC分类号: A61K9/00 , A61K31/357 , A61K31/498 , A61K47/10 , A61K47/32 , A61K47/34 , A61K47/36
摘要: Polymeric eye inserts are provided that may be dissolvable when placed in the cul-de-sac of the eye. These inserts may contain one or more mucoadhesive polymers polymers, a biodegradable polymer as well as softener/plasticizer so that, when inserted into the eye, they may absorb tears, and dissolve and slowly release lubricant into the tear film to lubricate and protect the ocular surface for an extended duration of time. The biodegradable polymer containing eye insert may increase dissolution time on the ocular surface for longer lasting relief, may reduce dosing frequency and patient burden typically associated with topical drop usage. These polymeric eye inserts also may include one or more pharmaceutically active agents.
-
公开(公告)号:US11376275B2
公开(公告)日:2022-07-05
申请号:US17060343
申请日:2020-10-01
申请人: Alcon Inc.
发明人: James W. Davis , Howard Allen Ketelson , Elaine E. Campbell , David L. Meadows , Rekha Rangarajan
IPC分类号: A61K31/736 , A61K9/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/36 , A61K47/32 , A61K31/728
摘要: The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the to compositions also comprise a borate compound.
-
8.
公开(公告)号:US11779537B2
公开(公告)日:2023-10-10
申请号:US17808342
申请日:2022-06-23
申请人: Alcon Inc.
IPC分类号: A61K9/00 , A61K31/357 , A61K31/498 , A61K47/10 , A61K47/32 , A61K47/34 , A61K47/36
CPC分类号: A61K9/0051 , A61K31/357 , A61K31/498 , A61K47/10 , A61K47/32 , A61K47/34 , A61K47/36
摘要: Polymeric eye inserts are provided that may be dissolvable when placed in the cul-de-sac of the eye. These inserts may contain one or more mucoadhesive polymers, a biodegradable polymer as well as softener/plasticizer so that, when inserted into the eye, they may absorb tears, and dissolve and slowly release lubricant into the tear film to lubricate and protect the ocular surface for an extended duration of time. The biodegradable polymer containing eye insert may increase dissolution time on the ocular surface for longer lasting relief, may reduce dosing frequency and patient burden typically associated with topical drop usage. These polymeric eye inserts also may include one or more pharmaceutically active agents.
-
公开(公告)号:US11730699B2
公开(公告)日:2023-08-22
申请号:US17147007
申请日:2021-01-12
申请人: Alcon Inc.
IPC分类号: A61K31/736 , A61P27/02 , A61K9/00 , A61K9/107 , A61K47/14 , A61K47/24 , B01F17/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/34 , A61K47/36 , B82Y5/00
CPC分类号: A61K9/1075 , A61K9/0048 , A61K47/02 , A61K47/24 , A61K47/26 , A61K47/34 , A61K47/36 , B82Y5/00
摘要: The present invention is directed to a lipid-based ophthalmic emulsion. The emulsion has an increased amount of a mucoadhesive galactomannan polymer that promotes a long-lasting protection against desiccation and moisture retention.
-
公开(公告)号:US11672820B2
公开(公告)日:2023-06-13
申请号:US17664143
申请日:2022-05-19
申请人: Alcon Inc.
发明人: James W. Davis , Howard Allen Ketelson , Elaine E. Campbell , David L. Meadows , Rekha Rangarajan
IPC分类号: A61K31/736 , A61K9/00 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/36 , A61K47/32 , A61K31/728
CPC分类号: A61K31/736 , A61K9/0048 , A61K31/728 , A61K47/02 , A61K47/10 , A61K47/26 , A61K47/32 , A61K47/36
摘要: The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the compositions also comprise a borate compound.
-
-
-
-
-
-
-
-
-